Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Liver damage related to immune checkpoint inhibitors — Naoshi Nishida (2019) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Liver damage related to immune checkpoint inhibitors
Shared by
Masatoshi Kudo
Liver damage related to immune checkpoint inhibitors
Article
2019
en
Authors
NN
Naoshi Nishida
Masatoshi Kudo
Related publications
Article
2021
Immune checkpoint inhibitors
Guido Guido Kroemer
,
Laurence Zitvogel
Article
2022
How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?
Yasunori Minami
,
Haruyuki Takaki
,
Koichiro Yamakado
,
Masatoshi Kudo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2021
Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors
Christopher A. Muir
,
Alexander M. Menzies
,
Roderick Clifton‐Bligh
,
Georgina V. Long
,
Richard A Scolyer
,
Venessa Tsang
Article
2024
Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors
Linda Y. Wu
,
Sarah Cappuyns
,
Amanda S. Loh
,
Sean Sun
,
Sara Lewis
,
Max W. Sung
,
Myron Schwartz
,
Josep M. Llovet
,
Deirdre Jill Cohen
BJC Reports
Letter
2017
Immune checkpoint inhibitors in malignant pleural mesothelioma
Giovanni Luca Ceresoli
,
Alberto Mantovani
Discussion(0)
No comments yet. Be the first to comment.